Alcon Inc. Newsletter
-
Alcon introduces presbyopia-correcting IOL Clareon PanOptix Pro in the US
08 Apr 2025 10:20 GMT
Alcon has now introduced its new Clareon PanOptix Pro intraocular lens (IOL) for patients with cataracts in the US. The presbyopia-correcting IOL will be Alcon’s first to be available in the US in the company’s single-use Clareon AutonoMe preloaded …
-
Alcon Scoops Up Aurion Biotech With Intent of Advancing Ophthalmology Cell Therapy AURN001
07 Apr 2025 12:25 GMT
… and commercial capabilities”, that Alcon has at its disposal, according … look forward to leveraging Alcon’s global resources and … from the US Food and Drug Administration (FDA) in June … ;20250326223440/en/Alcon-Acquires-Majority-Interest-in-Aurion …
-
Swiss pharma sector could face steep US tariffs
04 Apr 2025 14:03 GMT
… .”
“We are looking at pharma right now. Pharmaceuticals. It’s a separate … 32%. However, some goods, including pharmaceuticals, have been temporarily exempted.
Healthcare … Friday. Shares of Sandoz, Novartis, Alcon, Straumann, Lonza Roche and Sonova …
-
Alcon introduces the first fully personalized LASIK treatment, wavelight plus, in India with CDSCO approval
03 Apr 2025 13:20 GMT
…
Wavelight plus has received Central Drugs Standard Control Organisation (CDSCO) India … said Amar Vyas, country head, Alcon India.
“Wavelight plus is … are excited to offer Alcon’s latest innovation in … a new chapter in Alcon’s longstanding commitment to …
-
Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update
03 Apr 2025 20:05 GMT
… a large multi-national pharmaceutical customer. These new and … unamortized discount, under the Alcon term loans due to interest … unamortized discount, of the Alcon term loans due to … and finish of sterile injectable pharmaceutical products in syringes, vials …
-
Innovations in Diabetes-Related Eye Care Drive Growth in Ophthalmic Treatment Market
08 Apr 2025 11:09 GMT
… treatment solutions.
In 2023, Daewoong Pharmaceutical introduced Eylea eye drops, aiming … Profiled in the Report Include:
Alcon
Johnson & Johnson Services, … (Revenue, USD Billion; 2020-2033)
Drugs
Devices
By Application Outlook (Revenue …
-
Cutting back on steroid drops after cataract surgery: What are the alternatives?
07 Apr 2025 20:07 GMT
… well as topical anti-inflammatory drugs to combat inflammation, with a … reports consulting for Alcon, Bausch + Lomb and Tarsus Pharmaceuticals. Walter reports no …
-
Patient Satisfaction with a Novel Daily Toric Contact Lens in Individuals with Previous Lens Failures
07 Apr 2025 17:09 GMT
… lens (Dailies Total1® for Astigmatism; Alcon Laboratories, Inc., Fort Worth, Texas … Total1® for Astigmatism (delefilcon A, Alcon Laboratories, Inc., Fort Worth, TX … from Alcon for the study and is a consultant for Tarsus Pharmaceuticals …
-
Tech Moves: Gennev founder steps down; Aurion Biotech CEO is out; Temporal adds president
04 Apr 2025 00:36 GMT
… its CEO. Swiss healthcare company Alcon last week acquired a majority … eye diseases.
Following that deal, Alcon jettisoned founder and CEO Greg … the U.S. Food and Drug Administration that should expedite development …
-
The Escalator: HHS, Spectrum Science, Alvotech and more
03 Apr 2025 18:15 GMT
… Sara Carter as the drug czar to oversee the … Office of National Drug Control Policy.
Gameday Men … on administrative leave.
Traws Pharma announced Werner Cautreels, PhD will … to “pursue external opportunities.”
Alcon acquired a majority stake in …